90 related articles for article (PubMed ID: 27658010)
21. Recent advances on cyclodepsipeptides: biologically active compounds for drug research.
Liu SX; Ou-Yang SY; Lu YF; Guo CL; Dai SY; Li C; Yu TY; Pei YH
Front Microbiol; 2023; 14():1276928. PubMed ID: 37849925
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of complex head-to-side-chain cyclodepsipeptides.
Pelay-Gimeno M; Albericio F; Tulla-Puche J
Nat Protoc; 2016 Oct; 11(10):1924-1947. PubMed ID: 27658010
[TBL] [Abstract][Full Text] [Related]
23. Pegylated peptides. II. Solid-phase synthesis of amino-, carboxy- and side-chain pegylated peptides.
Lu YA; Felix AM
Int J Pept Protein Res; 1994 Feb; 43(2):127-38. PubMed ID: 8200730
[TBL] [Abstract][Full Text] [Related]
24. Solid-Phase Synthesis of Head to Side-Chain Tyr-Cyclodepsipeptides Through a Cyclative Cleavage From Fmoc-MeDbz/MeNbz-resins.
Acosta GA; Murray L; Royo M; de la Torre BG; Albericio F
Front Chem; 2020; 8():298. PubMed ID: 32391324
[TBL] [Abstract][Full Text] [Related]
25. Solid-Phase Total Synthesis of Bacitracin A.
Lee J; Griffin JH; Nicas TI
J Org Chem; 1996 Jun; 61(12):3983-3986. PubMed ID: 11667271
[TBL] [Abstract][Full Text] [Related]
26. New t-butyl based aspartate protecting groups preventing aspartimide formation in Fmoc SPPS.
Behrendt R; Huber S; Martí R; White P
J Pept Sci; 2015 Aug; 21(8):680-7. PubMed ID: 26077723
[TBL] [Abstract][Full Text] [Related]
27. Divergent solid-phase synthesis of natural product-inspired bipartite cyclodepsipeptides: total synthesis of seragamide A.
Arndt HD; Rizzo S; Nöcker C; Wakchaure VN; Milroy LG; Bieker V; Calderon A; Tran TT; Brand S; Dehmelt L; Waldmann H
Chemistry; 2015 Mar; 21(14):5311-6. PubMed ID: 25694199
[TBL] [Abstract][Full Text] [Related]
28. Ester coupling reactions--an enduring challenge in the chemical synthesis of bioactive natural products.
Tsakos M; Schaffert ES; Clement LL; Villadsen NL; Poulsen TB
Nat Prod Rep; 2015 Apr; 32(4):605-32. PubMed ID: 25572105
[TBL] [Abstract][Full Text] [Related]
29. A new antibiotic kills pathogens without detectable resistance.
Ling LL; Schneider T; Peoples AJ; Spoering AL; Engels I; Conlon BP; Mueller A; Schäberle TF; Hughes DE; Epstein S; Jones M; Lazarides L; Steadman VA; Cohen DR; Felix CR; Fetterman KA; Millett WP; Nitti AG; Zullo AM; Chen C; Lewis K
Nature; 2015 Jan; 517(7535):455-9. PubMed ID: 25561178
[TBL] [Abstract][Full Text] [Related]
30. Cyclic depsipeptides as potential cancer therapeutics.
Kitagaki J; Shi G; Miyauchi S; Murakami S; Yang Y
Anticancer Drugs; 2015 Mar; 26(3):259-71. PubMed ID: 25419631
[TBL] [Abstract][Full Text] [Related]
31. Total synthesis and antibacterial testing of the A54556 cyclic acyldepsipeptides isolated from Streptomyces hawaiiensis.
Goodreid JD; Wong K; Leung E; McCaw SE; Gray-Owen SD; Lough A; Houry WA; Batey RA
J Nat Prod; 2014 Oct; 77(10):2170-81. PubMed ID: 25255326
[TBL] [Abstract][Full Text] [Related]
32. Marine sponge derived natural products between 2001 and 2010: trends and opportunities for discovery of bioactives.
Mehbub MF; Lei J; Franco C; Zhang W
Mar Drugs; 2014 Aug; 12(8):4539-77. PubMed ID: 25196730
[TBL] [Abstract][Full Text] [Related]
33. Cyclodepsipeptides: a rich source of biologically active compounds for drug research.
Sivanathan S; Scherkenbeck J
Molecules; 2014 Aug; 19(8):12368-420. PubMed ID: 25153863
[TBL] [Abstract][Full Text] [Related]
34. Automated synthesis of backbone protected peptides.
Abdel-Aal AB; Papageorgiou G; Quibell M; Offer J
Chem Commun (Camb); 2014 Aug; 50(61):8316-9. PubMed ID: 24938489
[TBL] [Abstract][Full Text] [Related]
35. Stellatolides, a new cyclodepsipeptide family from the sponge Ecionemia acervus: isolation, solid-phase total synthesis, and full structural assignment of stellatolide A.
Martín MJ; Rodríguez-Acebes R; García-Ramos Y; Martínez V; Murcia C; Digón I; Marco I; Pelay-Gimeno M; Fernández R; Reyes F; Francesch AM; Munt S; Tulla-Puche J; Albericio F; Cuevas C
J Am Chem Soc; 2014 May; 136(18):6754-62. PubMed ID: 24725163
[TBL] [Abstract][Full Text] [Related]
36. Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development.
Newman DJ; Cragg GM
Mar Drugs; 2014 Jan; 12(1):255-78. PubMed ID: 24424355
[TBL] [Abstract][Full Text] [Related]
37. The first total synthesis of the cyclodepsipeptide pipecolidepsin A.
Pelay-Gimeno M; García-Ramos Y; Jesús Martin M; Spengler J; Molina-Guijarro JM; Munt S; Francesch AM; Cuevas C; Tulla-Puche J; Albericio F
Nat Commun; 2013; 4():2352. PubMed ID: 23989475
[TBL] [Abstract][Full Text] [Related]
38. "Head-to-side-chain" cyclodepsipeptides of marine origin.
Pelay-Gimeno M; Tulla-Puche J; Albericio F
Mar Drugs; 2013 May; 11(5):1693-717. PubMed ID: 23697952
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
